This inventor holds 8 USPTO granted patents and 13 published patent applications. Top assignee: Ripple Therapeutics Corporation. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2025
Title: The Innovative Contributions of Matthew Alexander John Statham
Introduction
Matthew Alexander John Statham, an accomplished inventor based in Milton, CA, has made significant strides in the field of ocular therapeutics. With a total of six patents to his name, Statham's work focuses on advancing treatments for various ocular disorders.
Latest Patents
Statham's most recent patents highlight his dedication to innovation in ocular therapeutics. One of his notable inventions is an "Ocular insert comprising a covalently linked steroid dimer," which discloses compounds and compositions designed for the sustained release of ocular therapeutics. Another significant patent, “Heterodimer compositions and methods for the treatment of ocular disorders,” details processable compositions that include steroids and prostaglandins, demonstrating anti-inflammatory activity and lowering intraocular pressure (IOP). These inventions collectively address a range of ocular diseases, including glaucoma, blepharitis, and macular degeneration, among others.
Career Highlights
Matthew Statham currently works for Ripple Therapeutics Corporation, where he continues to pioneer research and develop solutions aimed at improving ocular health. His expertise and inventive spirit have positioned him as a prominent figure in the realm of ophthalmic innovation.
Collaborations
Throughout his tenure at Ripple Therapeutics Corporation, Statham has collaborated with talented colleagues, including Ian Charles Parrag and Kyle Giovanni Battiston. This team of innovators works collectively to push the boundaries of research and translate scientific discoveries into viable treatments for patients.
Conclusion
Matthew Alexander John Statham's contributions to ocular therapeutics demonstrate the profound impact of dedicated inventors in the medical field. With a focus on innovative solutions for ocular disorders, Statham continues to shape the future of ocular health, while his patents pave the way for improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile